Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Keeps you up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Additional Business Intelligence Offerings
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
U.S. Lab Sector Globalizes with Foreign Deals
From - Laboratory Industry Report
For the better part of a century, laboratories had been among the most local of health care providers. But in recent decades, that dynamic has taken a 180-degree turn…
Genetic Risk of Disease Results Don’t Change Health-Related Behaviors
From - Diagnostic Testing & Emerging Technologies
Communicating genetic risk of disease estimates does not impact individuals' health related behaviors, according to a review published March 15 in the…
Second Doctor Indicted in Biodiagnostic Kickback Case
From - Laboratory Industry Report
Another physician has been indicted in the long-running Biodiagnostic Laboratory Services case. Bernard Greenspan, M.D., a family physician in Northern New Jersey, was indicted on…
Recent $3.9 Million Settlement and Task Force Announcement Focus Attention on Health Care Information Security
From - National Intelligence Report
A $3.9 million settlement arising from a potential HIPAA breach and an announcement regarding a U.S. Department of Health and Human Services Task Force emphasize the…
New Breast Cancer Staging System Incorporates HER2 Status to Better Assess Prognosis
From - Diagnostic Testing & Emerging Technologies
A new breast cancer staging system adds HER2 (ERBB2-positive disease) status to a list of factors used to assess prognosis in women who undergo neoadjuvant (pre-surgical) therapy for…